Management of Elevated Ferritin Levels

Diagnostic Approach

Measure transferrin saturation (TS) alongside ferritin to better assess iron status, crucial for distinguishing between true iron overload, anemia of chronic disease, and inflammatory conditions, as recommended by the American Gastroenterological Association 1
Consider common causes of elevated ferritin, including inflammatory conditions (acute phase response) 2, liver disease (alcoholic, viral hepatitis, NAFLD) 3, and hereditary hemochromatosis (HFE-related) 4

If TS ≥ 45% with elevated ferritin, consider iron overload disorders, with a strength of evidence level of high, according to the American Association for the Study of Liver Diseases 5, 2
If TS < 45% with elevated ferritin, consider inflammatory conditions, anemia of chronic disease, or liver disease, with a moderate level of evidence, as suggested by the American Gastroenterological Association 5, 1

Ferritin < 1000 μg/L: Lower risk of organ damage, with a low level of evidence, according to the American Association for the Study of Liver Diseases 3
Ferritin > 1000 μg/L: Higher risk of advanced fibrosis/cirrhosis in iron overload conditions, with a high level of evidence, as recommended by the American Association for the Study of Liver Diseases 3, 5

For confirmed hemochromatosis (C282Y homozygotes with iron overload), therapeutic phlebotomy is the cornerstone of treatment, with a high level of evidence, according to the American Gastroenterological Association 4
Weekly phlebotomy (removal of 500 mL blood) until ferritin reaches 50-100 μg/L, with a moderate level of evidence, as suggested by the American Association for the Study of Liver Diseases 4
Maintenance phlebotomy to keep ferritin between 50-100 μg/L, with a high level of evidence, according to the American Gastroenterological Association 4

In patients with both iron overload and liver disease, address both conditions, with a moderate level of evidence, as recommended by the American Association for the Study of Liver Diseases 3
Failing to screen first-degree relatives of patients with HFE-related hemochromatosis, with a high level of evidence, according to the American Gastroenterological Association 3

For patients on phlebotomy, check hemoglobin/hematocrit before each procedure and ferritin every 10-12 phlebotomies, with a moderate level of evidence, as suggested by the American Association for the Study of Liver Diseases 4
Avoid vitamin C supplements and iron supplements in those with confirmed iron overload, with a high level of evidence, according to the American Gastroenterological Association 4

The American Association for the Study of Liver Diseases recommends immediate evaluation for hemochromatosis with HFE genetic testing and transferrin saturation in patients with ferritin ≥1000 μg/L and markedly elevated transaminases 6, 7
If transferrin saturation ≥45%, proceed directly to HFE genotype testing to confirm hereditary hemochromatosis 6
If ferritin ≥1000 μg/L, consider liver biopsy to assess for cirrhosis, as this threshold carries a 20-45% prevalence of cirrhosis in C282Y homozygotes 6, 8

Patients with ferritin ≥1000 μg/L and markedly elevated AST are at high risk for advanced fibrosis/cirrhosis 6, 8, 9
The combination of elevated ALT and ferritin >1000 μg/L confers a significantly increased risk for substantial iron overload 6, 8

Liver biopsy should be strongly considered in patients with ferritin >1000 μg/L and abnormal liver tests, as it has 100% sensitivity and 70% specificity for identifying cirrhosis 6, 8
No patient with ferritin <1000 μg/L had cirrhosis in validation studies, but all patients with cirrhosis had ferritin >1000 μg/L 6, 8

The American Association for the Study of Liver Diseases recommends screening all first-degree relatives with iron studies and HFE mutation analysis (Grade 1A recommendation) 6, 7

With early diagnosis and treatment before cirrhosis develops, prognosis is excellent, and therapeutic phlebotomy can prevent cirrhosis, hepatocellular carcinoma, and other complications 6, 9